Successful challenge to the selection of a drug for AbbVie
We secured the first successful challenge to price controls under the Drug Price Negotiation Program
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
bit.bio $25 million series D equity financing
We are advising the company on the funding round
Bread Financial $121.1 million preferred stock offering
We advised Bread Financial on the offering
Textron $350 million notes offering
We advised the underwriters on the offering
FuriosaAI $620 million Series D financing
We advised FuriosaAI on the transaction
Sands China $1 billion notes offering
We advised the joint book-running managers on the offering
Perion $420 million merger with Affle
We are advising Perion on the transaction
Meta Platforms recapitalization
We advised Meta on the transaction
Meta Platforms $37.5 billion equity and equity-linked offerings
We advised Meta on its historic equity and equity-linked offerings
Lumentum $115 billion combination with Marvell
We are advising Lumentum on the transaction